65 Participants Needed

PACT Training for Oncology Nursing Care

TZ
Overseen ByTalia Zaider, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Memorial Sloan Kettering Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The purpose of this study is to find out if a new training program for nurses called PACT (Partnership, Assessment, Care, and Transition) will be effective and relevant in helping nurses gain the skills needed to provide high-quality family-centered care. Family-centered care skills include engaging family caregivers as partners in patient care, and strengthening their capacity for caregiving by assessing family support needs and facilitating access to resources when needed. The study will also look at whether the quality of nurses' family-centered care skills is associated with improved outcomes for family caregivers. Both nurses and family caregivers will be enrolled in this study. Participants will be nurses/caregivers who care for advanced GI cancer patients admitted to Memorial Sloan Kettering.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What data supports the effectiveness of the PACT Training for Oncology Nursing Care treatment?

Research shows that patient-centered nursing interventions, like those in the PACT training, can improve patient outcomes such as well-being and trust in nurses. Additionally, effective distress assessment and management, which is part of PACT, can enhance patients' quality of life during cancer treatment.12345

Is PACT Training for Oncology Nursing Care safe for humans?

The available research does not provide specific safety data for PACT Training for Oncology Nursing Care, but it emphasizes the importance of patient safety education in reducing medical errors and improving safety in oncology settings.678910

How does PACT Training for Oncology Nursing Care differ from other treatments for cancer care?

PACT Training for Oncology Nursing Care is unique because it focuses on enhancing the skills and competencies of oncology nurses through specialized training, rather than directly treating the cancer itself. This approach aims to improve the quality of care provided to cancer patients by equipping nurses with advanced knowledge and skills, which is different from traditional treatments that focus on medical interventions.211121314

Research Team

Talia I. Zaider, PhD - MSK Psychologist

Talia Zaider, PhD

Principal Investigator

Memorial Sloan Kettering Cancer Center

Eligibility Criteria

This trial is for English-speaking nurses working day shifts in the GI unit at Memorial Sloan Kettering, and family caregivers of adult GI cancer patients admitted there. Caregivers must be involved in patient care but cannot participate if their patient has passed away or they were part of an earlier study phase.

Inclusion Criteria

I am an MSKCC nurse on the GI unit, comfortable with English.

Exclusion Criteria

I am a nurse planning to leave my current position or refuse observation within 3 months.
Family caregivers (FC) - Phases 1b, 2, 4: FC participated in an earlier study phase. FC's patient is deceased at time of consent.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Training

Nurses undergo the PACT training program to enhance family-centered care skills

4 weeks

Implementation

Nurses implement family-centered care practices in the GI inpatient unit

30 days
Ongoing assessments during shifts

Follow-up

Participants are monitored for the effectiveness of family-centered care practices

4 weeks

Treatment Details

Interventions

  • Partnership, Assessment, Care and Transition training intervention
Trial Overview The PACT (Partnership, Assessment, Care, and Transition) training program is being tested to see if it improves nurses' skills in providing family-centered care. The impact on caregiver outcomes will also be assessed.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: NursesExperimental Treatment1 Intervention
MSKCC day-shift nurses (Clinical Nurse I to IV) assigned to the GI inpatient unit (MH16) at the time of study, all of whom provide initial and ongoing assessment of patients' physical, psychosocial, cultural and informational needs

Find a Clinic Near You

Who Is Running the Clinical Trial?

Memorial Sloan Kettering Cancer Center

Lead Sponsor

Trials
1,998
Recruited
602,000+

Findings from Research

The NCCN Third Annual Patient Safety Summit focused on improving patient safety in oncology by addressing medication reconciliation, communication during patient hand-offs, and reporting near-miss events, highlighting the importance of these processes in preventing adverse events.
Key strategies discussed included transitioning from paper to electronic systems and enhancing education and training for healthcare teams, emphasizing that every team member plays a crucial role in maintaining patient safety.
Report on the NCCN Third Annual Patient Safety Summit.Hinkel, JM.[2019]
A 1-day patient safety program for third-year medical students, which included online modules and simulation scenarios, was well-received with an average evaluation score of 4.2/5, indicating its effectiveness in teaching safety principles.
The program increased awareness of patient safety issues among students, with 59% reporting they were previously unaware of system-based safety approaches, and it empowered them to act on safety concerns, potentially reducing adverse events in oncology care.
Advancing the Future of Patient Safety in Oncology: Implications of Patient Safety Education on Cancer Care Delivery.James, TA., Goedde, M., Bertsch, T., et al.[2018]
A new model for patient participation in intravenous chemotherapy safety was developed based on a comprehensive review of chemotherapy-related adverse events and existing patient safety strategies, which can help reduce adverse reactions in cancer patients.
The model, refined through a Delphi-method questionnaire with an 82.36% response rate, includes detailed indicators for patient involvement and responsibilities of medical personnel, providing a structured approach for nurse practitioners to enhance patient safety during chemotherapy.
A developed model of cancer patients participation in intravenous chemotherapy safety.Na, Z., Qiaoyuan, Y., Binghan, W., et al.[2019]

References

Oncology clinical nurse specialists' perceptions of their influence on patient outcomes. [2019]
Incorporating breast cancer care data into clinical assessment. [2014]
Improving psychosocial assessment in a community-based cancer center. [2014]
Relationships between patient-centered cancer nursing interventions and desired health outcomes in the context of the health care system. [2022]
What Nursing-Sensitive Outcomes Have Been Investigated to Date among Patients with Solid and Hematological Malignancies? A Scoping Review. [2023]
Oncology nurses' perceptions about involving patients in the prevention of chemotherapy administration errors. [2013]
Report on the NCCN Third Annual Patient Safety Summit. [2019]
Advancing the Future of Patient Safety in Oncology: Implications of Patient Safety Education on Cancer Care Delivery. [2018]
Categorizing errors and adverse events for learning: a provider perspective. [2019]
10.United Statespubmed.ncbi.nlm.nih.gov
A developed model of cancer patients participation in intravenous chemotherapy safety. [2019]
Core competencies for the training of advanced practice nurses in oncology: a Delphi study. [2022]
Building A High Quality Oncology Nursing Workforce Through Lifelong Learning: The De Souza Model. [2018]
Dynamics and processes influencing role integration of advanced practice nurses and nurse navigators in oncology teams. [2023]
Professional competencies of oncology nurses: Recognizing advanced practice in nursing. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security